Pergolide Mesylate — CAS 66104-23-2

Pergolide Mesylate is the methanesulfonate salt of Pergolide, the ergoline dopamine agonist. Mediocon Inc manufactures this high-purity API at its GMP-certified facility in Aurangabad, Maharashtra, India. The mesylate salt form provides improved pharmaceutical stability and solubility compared to the free base. Pergolide Mesylate was the commercially approved form (Permax) and remains widely used in veterinary medicine for equine PPID. It exhibits potent D1 and D2 receptor agonist activity.

• Adjunctive therapy in Parkinson's disease with levodopa (human pharma)
• Equine Pituitary Pars Intermedia Dysfunction (PPID/Cushing's) — veterinary use
• Dopaminergic research applications
• API supply for Pergolide mesylate tablet and oral formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support